Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
Corcept Therapeutics reports 2020 executive compensation
By ExecPay News
Published: April 22, 2021
Corcept Therapeutics reported fiscal year 2020 executive compensation information on April 22, 2021.
In 2020, five executives at Corcept Therapeutics received on average a compensation package of $3.3M, a 2% decrease compared to previous year.
Average pay of disclosed executives at Corcept Therapeutics
Joseph K. Belanoff, Chief Executive Officer, received $5.8M in total, which increased by 16% compared to 2019. 74% of Belanoff's compensation, or $4.2M, was in option awards. Belanoff also received $744K in bonus, $770K in salary, as well as $11K in other compensation.
Sean Maduck, Chief Commercial Officer, received a compensation package of $3.2M, which increased by 43% compared to previous year. 78% of the compensation package, or $2.5M, was in option awards.
Charles Robb, Secretary, earned $2.9M in 2020, a 12% increase compared to previous year.
Hazel Hunt, Chief Scientific Officer, received $2.8M in 2020.
Andreas Grauer, Chief Medical Officer, earned $2.1M in 2020, a 46% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 22, 2021.